CEACAM5 and carcinoma: In line with these results, it has already been shown that PIK3CA variants reflect responses to therapies more accurately than carcinoembryonic antigen (CEA) or carcinoma antigen 15-3 (CA15-3) [8] and that changes in PIK3CA ctDNA levels correlated with treatment response [37,44].